Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,411.20
(
-2.35%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.89
(
0.00%
)
Bitcoin
66,187.09
(
-0.23%
)
News Focus
News Focus

Replies to post #220446 on Biotech Values

Replies to #220446 on Biotech Values
icon url

DewDiligence

08/10/18 10:45 AM

#220453 RE: Biowatch #220446

ENTA is basing its royalty guidance for the next two quarters (#msg-142751191) on $3.6B of 2018 Mavyret sales, since ABBV recently raised its guidance from $3.5B to more than $3.5B.